Biomarkers Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Genomics, proteomics and multi-omics at Biomarkers Europe 2026

Oct 13–14, 2026 Basel, Switzerland ~1k attendees Website

58 organizations at Biomarkers Europe 2026 present work in genomics, proteomics and multi-omics: 42 technology and service providers, 12 academic, government and non-profit bodies and 4 drug developers. Between them they bring 64 presentations to the program. Most represented: Novartis (8 on the program), Labcorp (7 on the program), AstraZeneca (4 on the program). As of Oct 8, 2026.

All 137 organizations at Biomarkers Europe 2026 →

Format
Top represented
Showing 1–12 of 58 organizations
OrganizationBiomarkers Europe 2026 Attendance
Novartis
Basel, Switzerland
Large pharma
Swiss pharmaceutical company with marketed medicines in oncology, immunology, neuroscience and cardiovascular disease.
Talk
Tue Oct 13
9:15am–9:40am
Precision Medicine Beyond the Hype: Delivering Real Clinical Impact
Drug–diagnostic commercialization & access
Panel
Tue Oct 13
12:40pm–1:30pm
Application And Integration Of Proteomic Biomarkers In Precision Medicine
with BioAge Labs, Engitix, Cancer Research UK +2 more
Genomics, proteomics and multi-omicsBiomarker discovery & translation
Talk
Tue Oct 13
2:30pm–2:55pm
Spatial Autoimmunity - Challenges and Opportunities in Salivary Glands
with 10x Genomics
Digital pathology & spatial biomarkers
Talk
Tue Oct 13
2:55pm–3:20pm
Translational Biomarkers For Evaluating Biologic Drug Efficacy
Biomarker discovery & translation
Talk
Tue Oct 13
3:20pm–3:45pm
Leveraging UK Biobank to Derive Proteomic Signatures Representative of Disease Biology of Dermatological Indications
with Olink
Genomics, proteomics and multi-omics
Talk
Wed Oct 14
9:10am–9:35am
Digital Health Technology Adoption In Clinical Development
Multimodal & AI-enabled precision medicineDrug–diagnostic commercialization & access
Panel
Wed Oct 14
1:00pm–1:30pm
Biomarker Strategies In Neurodegenerative Therapeutics
with Lundbeck, Cure Parkinson's, Neuro-Bio +2 more
Biomarker discovery & translation
Panel
Wed Oct 14
3:15pm–4:05pm
AI-Enabled Clinical Trial Innovation - From Biomarker Data To Decision
with Merck Healthcare
Multimodal & AI-enabled precision medicine
Labcorp
Burlington, NC
◆Diamond Sponsor
CROs & central labsDiamond Sponsor
Laboratory services company offering diagnostic testing, central lab and biomarker services for drug trials, and companion diagnostic development.
Talk
Tue Oct 13
9:40am–10:05am
Advancing Precision Oncology with Companion Diagnostics: Accelerating Development with elio™ Tissue Complete CDx
Clinical & companion diagnostic developmentGenomics, proteomics and multi-omics
Talk
Tue Oct 13
3:20pm–3:45pm
An Open Approach To Biomarker Discovery And Companion Diagnostics
with Proscia
Biomarker discovery & translationClinical & companion diagnostic development
Workshop
Wed Oct 14
11:20am–1:20pm
Enabling Global Precision Oncology Through Integrated Testing, Monitoring, and Companion Diagnostic Strategies
Clinical & companion diagnostic development
Talk
Wed Oct 14
2:50pm–3:15pm
From Biomarkers To Biological Signatures: Enabling Precision Prevention And Clinical Trials In Cardiometabolic Disease
Biomarker discovery & translation
AstraZeneca
Cambridge, UK
Large pharma
Global pharmaceutical company developing and marketing medicines in oncology, cardiovascular, renal, respiratory and rare diseases.
Talk
Tue Oct 13
9:15am–9:40am
From Digital Pathology To Precision Medicine: Scaling AI-Driven Image Analysis
Digital pathology & spatial biomarkersMultimodal & AI-enabled precision medicine
Panel
Tue Oct 13
12:40pm–1:30pm
Application And Integration Of Proteomic Biomarkers In Precision Medicine
with BioAge Labs, Novartis, Engitix +2 more
Genomics, proteomics and multi-omicsBiomarker discovery & translation
Panel
Tue Oct 13
12:40pm–1:30pm
Overcoming Challenges In Deploying Foundation Models, LLMs And Agentic AI For Pathology Workflows
with Betsi Cadwaladr University Health Board, Roche
Multimodal & AI-enabled precision medicineDigital pathology & spatial biomarkers
Panel
Tue Oct 13
5:10pm–6:00pm
AI-Powered Precision Medicine
with GSK, Healiva, Roche
Multimodal & AI-enabled precision medicine
Panel
Wed Oct 14
8:05am–8:30am
Bringing Digital & AI Into The Clinic: How To Globalise Computational Pathology
Digital pathology & spatial biomarkersMultimodal & AI-enabled precision medicine
Talk
Wed Oct 14
11:45am–12:10pm
Digital Biomarkers, Cancer Networks And Clinical Action
Multimodal & AI-enabled precision medicine
Panel
Wed Oct 14
1:00pm–1:30pm
Deploying Computational Pathology Across The Pharma Pipeline
with StratifAI, Deciphex, UCB +1 more
Digital pathology & spatial biomarkersMultimodal & AI-enabled precision medicine
Illumina
San Diego, CA
◆Platinum Sponsor
Instruments & reagentsPlatinum Sponsor
Makes DNA and RNA sequencing systems and multiomic tools used for biomarker and drug target discovery.
Talk
Tue Oct 13
9:40am–10:05am
Submission required
Talk
Tue Oct 13
3:20pm–3:45pm
Illumina Presentation
Diagenode
Liège, Belgium
◇Bronze Sponsor
CROs & central labsBronze Sponsor
Epigenomics company, part of Hologic, offering methylation profiling and bioinformatics services for biomarker discovery, including liquid biopsy and MRD studies.
Talk
Tue Oct 13
3:45pm–4:10pm
Epigenomics At 360° In Liquid Biopsy​: Approaches And Case Studies For Biomarker Discovery And Drug Development​
Liquid biopsy & MRDGenomics, proteomics and multi-omics
Academic & healthcare
Cancer research institute of Queen Mary University of London working on early detection, tumour biology and clinical trials.
Panel
Tue Oct 13
12:40pm–1:30pm
Navigating The Multi-Omics Investment Landscape: How Investors See The Future Of The Field
with Flanders Investment & Trade, HealthSeed, Quant Biomarkers
Genomics, proteomics and multi-omicsDrug–diagnostic commercialization & access
Talk
Tue Oct 13
2:55pm–3:20pm
A Translational Journey To Pancreatic Cancer Detection
Biomarker discovery & translation
BioAge Labs
Richmond, CA
Biotech
Clinical-stage biotech developing drugs for obesity and metabolic diseases based on the biology of aging.
Panel
Tue Oct 13
12:40pm–1:30pm
Application And Integration Of Proteomic Biomarkers In Precision Medicine
with Novartis, Engitix, Cancer Research UK +2 more
Genomics, proteomics and multi-omicsBiomarker discovery & translation
Talk
Wed Oct 14
11:45am–12:10pm
Gov/NGO
UK cancer charity funding research into cancer prevention, early diagnosis and treatment.
Panel
Tue Oct 13
12:40pm–1:30pm
Application And Integration Of Proteomic Biomarkers In Precision Medicine
with BioAge Labs, Novartis, Engitix +2 more
Genomics, proteomics and multi-omicsBiomarker discovery & translation
Panel
Wed Oct 14
1:00pm–1:30pm
From Silos To Alliances – Rethinking Collaboration In Precision Medicine
with Flanders Investment & Trade, Step Pharma, AbbVie +1 more
Drug–diagnostic commercialization & access
Gov/NGO
Flemish government agency promoting international trade and foreign investment in Flanders, Belgium.
Panel
Tue Oct 13
12:40pm–1:30pm
Navigating The Multi-Omics Investment Landscape: How Investors See The Future Of The Field
with HealthSeed, Barts Cancer Institute, Queen Mary University of London, Quant Biomarkers
Genomics, proteomics and multi-omicsDrug–diagnostic commercialization & access
Panel
Wed Oct 14
1:00pm–1:30pm
From Silos To Alliances – Rethinking Collaboration In Precision Medicine
with Step Pharma, Cancer Research UK, AbbVie +1 more
Drug–diagnostic commercialization & access
Consulting & other services
Swiss healthcare venture studio building programs and partnerships to bring health innovations to market.
Panel
Tue Oct 13
12:40pm–1:30pm
Navigating The Multi-Omics Investment Landscape: How Investors See The Future Of The Field
with Flanders Investment & Trade, Barts Cancer Institute, Queen Mary University of London, Quant Biomarkers
Genomics, proteomics and multi-omicsDrug–diagnostic commercialization & access
Talk
Wed Oct 14
7:55am–8:15am
Breakfast Session: Investing in Precision Medicine: The Founder & Investor Perspective
Drug–diagnostic commercialization & access
One Biosciences
Paris, France
Diagnostics & testing labs
Institut Curie spin-off profiling tumour samples at single-cell resolution to produce clinical reports that guide cancer treatment choice.
Talk
Tue Oct 13
12:15pm–12:40pm
Clinical Single-Cell Sequencing To Uncover Determinants Of Response And Guide Treatment Selection
Genomics, proteomics and multi-omics
Panel
Tue Oct 13
1:05pm–1:30pm
Translating Biomarkers From Discovery To Clinical Use
with Lundbeck, Step Pharma, Monte Rosa Therapeutics +2 more
Biomarker discovery & translation
Almac
Craigavon, UK
◇Silver Sponsor
Diagnostics & testing labsSilver Sponsor
Diagnostic services arm of the Almac Group, running CLIA- and CAP-accredited labs for biomarker-led trials, multi-omic work, CDx development and clinical testing.
Talk
Tue Oct 13
9:40am–10:05am
Unlocking High-Quality NGS Data from Challenging Clinical Samples
Genomics, proteomics and multi-omics

Explore the full Biomarkers Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Basel. Leave your work email and we’ll be in touch.

Privacy

Download the full Biomarkers Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers in genomics, proteomics and multi-omics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Browse Biomarkers Europe 2026 by

Not affiliated with or endorsed by Biomarkers, CDx & Precision Medicine or its organizers. Submit a correction